Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 113

1.

Preparation of porcine enterotoxigenic Escherichia coli (ETEC) ghosts and immunogenic analysis in a mouse model.

Ran X, Chen X, Wang S, Chang C, Wen X, Zhai J, Ni H.

Microb Pathog. 2019 Jan;126:224-230. doi: 10.1016/j.micpath.2018.11.015. Epub 2018 Nov 11.

PMID:
30428380
2.

Select gp120 V2 domain specific antibodies derived from HIV and SIV infection and vaccination inhibit gp120 binding to α4β7.

Lertjuthaporn S, Cicala C, Van Ryk D, Liu M, Yolitz J, Wei D, Nawaz F, Doyle A, Horowitch B, Park C, Lu S, Lou Y, Wang S, Pan R, Jiang X, Villinger F, Byrareddy SN, Santangelo PJ, Morris L, Wibmer CK, Biris K, Mason RD, Gorman J, Hiatt J, Martinelli E, Roederer M, Fujikawa D, Gorini G, Franchini G, Arakelyan A, Ansari AA, Pattanapanyasat K, Kong XP, Fauci AS, Arthos J.

PLoS Pathog. 2018 Aug 28;14(8):e1007278. doi: 10.1371/journal.ppat.1007278. eCollection 2018 Aug.

3.

Using DNA Immunization to Elicit Monoclonal Antibodies in Mice, Rabbits, and Humans.

Liu S, Wang S, Lu S.

Hum Gene Ther. 2018 Sep;29(9):997-1003. doi: 10.1089/hum.2018.077.

PMID:
30027758
4.

Structural Comparison of Human Anti-HIV-1 gp120 V3 Monoclonal Antibodies of the Same Gene Usage Induced by Vaccination and Chronic Infection.

Chan KW, Pan R, Costa M, Gorny MK, Wang S, Lu S, Kong XP.

J Virol. 2018 Aug 29;92(18). pii: e00641-18. doi: 10.1128/JVI.00641-18. Print 2018 Sep 15.

5.

Rational Design of Yolk-Shell CuO/Silicalite-1@mSiO2 Composites for a High-Performance Nonenzymatic Glucose Biosensor.

Cheng X, Zhao H, Huang W, Chen J, Wang S, Dong J, Deng Y.

Langmuir. 2018 Jul 3;34(26):7663-7672. doi: 10.1021/acs.langmuir.8b01051. Epub 2018 Jun 19.

PMID:
29871483
6.

The wide utility of rabbits as models of human diseases.

Esteves PJ, Abrantes J, Baldauf HM, BenMohamed L, Chen Y, Christensen N, González-Gallego J, Giacani L, Hu J, Kaplan G, Keppler OT, Knight KL, Kong XP, Lanning DK, Le Pendu J, de Matos AL, Liu J, Liu S, Lopes AM, Lu S, Lukehart S, Manabe YC, Neves F, McFadden G, Pan R, Peng X, de Sousa-Pereira P, Pinheiro A, Rahman M, Ruvoën-Clouet N, Subbian S, Tuñón MJ, van der Loo W, Vaine M, Via LE, Wang S, Mage R.

Exp Mol Med. 2018 May 22;50(5):66. doi: 10.1038/s12276-018-0094-1. Review.

7.

Application of area scaling analysis to identify natural killer cell and monocyte involvement in the GranToxiLux antibody dependent cell-mediated cytotoxicity assay.

Pollara J, Orlandi C, Beck C, Edwards RW, Hu Y, Liu S, Wang S, Koup RA, Denny TN, Lu S, Tomaras GD, DeVico A, Lewis GK, Ferrari G.

Cytometry A. 2018 Apr;93(4):436-447. doi: 10.1002/cyto.a.23348. Epub 2018 Mar 2.

8.

Use of ELISpot assay to study HBs-specific B cell responses in vaccinated and HBV infected humans.

Tian C, Chen Y, Liu Y, Wang S, Li Y, Wang G, Xia J, Zhao XA, Huang R, Lu S, Wu C.

Emerg Microbes Infect. 2018 Feb 16;7(1):16. doi: 10.1038/s41426-018-0034-0.

9.

HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.

Quitadamo B, Peters PJ, Repik A, O'Connell O, Mou Z, Koch M, Somasundaran M, Brody R, Luzuriaga K, Wallace A, Wang S, Lu S, McCauley S, Luban J, Duenas-Decamp M, Gonzalez-Perez MP, Clapham PR.

J Virol. 2018 Jan 2;92(2). pii: e00841-17. doi: 10.1128/JVI.00841-17. Print 2018 Jan 15.

10.

The dynamics of immunoglobulin V-gene usage and clonotype expansion in mice after prime and boost immunizations as analyzed by NGS.

Farfán-Arribas DJ, Liu S, Wang S, Lu S.

Hum Vaccin Immunother. 2017 Dec 2;13(12):2987-2995. doi: 10.1080/21645515.2017.1379638. Epub 2017 Oct 19.

11.

Screening of primary gp120 immunogens to formulate the next generation polyvalent DNA prime-protein boost HIV-1 vaccines.

Wang S, Chou TH, Hackett A, Efros V, Wang Y, Han D, Wallace A, Chen Y, Hu G, Liu S, Clapham P, Arthos J, Montefiori D, Lu S.

Hum Vaccin Immunother. 2017 Dec 2;13(12):2996-3009. doi: 10.1080/21645515.2017.1380137. Epub 2017 Sep 21.

12.

An in-situ Raman study on pristane at high pressure and ambient temperature.

Wu J, Ni Z, Wang S, Zheng H.

Spectrochim Acta A Mol Biomol Spectrosc. 2018 Jan 15;189:215-220. doi: 10.1016/j.saa.2017.07.026. Epub 2017 Jul 19.

PMID:
28820973
13.

Cluster-Randomized, Crossover Trial of Head Positioning in Acute Stroke.

Anderson CS, Arima H, Lavados P, Billot L, Hackett ML, Olavarría VV, Muñoz Venturelli P, Brunser A, Peng B, Cui L, Song L, Rogers K, Middleton S, Lim JY, Forshaw D, Lightbody CE, Woodward M, Pontes-Neto O, De Silva HA, Lin RT, Lee TH, Pandian JD, Mead GE, Robinson T, Watkins C; HeadPoST Investigators and Coordinators.

N Engl J Med. 2017 Jun 22;376(25):2437-2447. doi: 10.1056/NEJMoa1615715.

14.

Differential induction of anti-V3 crown antibodies with cradle- and ladle-binding modes in response to HIV-1 envelope vaccination.

Balasubramanian P, Kumar R, Williams C, Itri V, Wang S, Lu S, Hessell AJ, Haigwood NL, Sinangil F, Higgins KW, Liu L, Li L, Nyambi P, Gorny MK, Totrov M, Nadas A, Kong XP, Zolla-Pazner S, Hioe CE.

Vaccine. 2017 Mar 7;35(10):1464-1473. doi: 10.1016/j.vaccine.2016.11.107. Epub 2017 Feb 6.

15.

Structural Analysis of the Glycosylated Intact HIV-1 gp120-b12 Antibody Complex Using Hydroxyl Radical Protein Footprinting.

Li X, Grant OC, Ito K, Wallace A, Wang S, Zhao P, Wells L, Lu S, Woods RJ, Sharp JS.

Biochemistry. 2017 Feb 21;56(7):957-970. doi: 10.1021/acs.biochem.6b00888. Epub 2017 Feb 6.

17.

Rationally Designed Immunogens Targeting HIV-1 gp120 V1V2 Induce Distinct Conformation-Specific Antibody Responses in Rabbits.

Jiang X, Totrov M, Li W, Sampson JM, Williams C, Lu H, Wu X, Lu S, Wang S, Zolla-Pazner S, Kong XP.

J Virol. 2016 Nov 28;90(24):11007-11019. Print 2016 Dec 15.

18.

Fc Receptor-Mediated Activities of Env-Specific Human Monoclonal Antibodies Generated from Volunteers Receiving the DNA Prime-Protein Boost HIV Vaccine DP6-001.

Costa MR, Pollara J, Edwards RW, Seaman MS, Gorny MK, Montefiori DC, Liao HX, Ferrari G, Lu S, Wang S.

J Virol. 2016 Oct 28;90(22):10362-10378. doi: 10.1128/JVI.01458-16. Print 2016 Nov 15.

19.

Rationally Designed Vaccines Targeting the V2 Region of HIV-1 gp120 Induce a Focused, Cross-Clade-Reactive, Biologically Functional Antibody Response.

Zolla-Pazner S, Powell R, Yahyaei S, Williams C, Jiang X, Li W, Lu S, Wang S, Upadhyay C, Hioe CE, Totrov M, Kong X.

J Virol. 2016 Nov 28;90(24):10993-11006. Print 2016 Dec 15.

20.

DNA immunization as a technology platform for monoclonal antibody induction.

Liu S, Wang S, Lu S.

Emerg Microbes Infect. 2016 Apr 6;5:e33. doi: 10.1038/emi.2016.27. Review.

Supplemental Content

Loading ...
Support Center